📣 VC round data is live. Check it out!
- Public Comps
- COSMAX
COSMAX Valuation Multiples
Discover COSMAX's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings and more.
COSMAX Overview
About COSMAX
Cosmax Inc is a Korean-based specialized cosmetics research and development and manufacturing company. COSMAX develops and provides cosmetics to more than 600 cosmetics brands around the world. The key product consists of skincare, makeup, mask sheets, oriental medicine, haircare, functional cosmetics, and scents. Its products are also sold in Europe, North America, and Central and South America. The company also has four corporations in Shanghai and Guangzhou, China, Indonesia, and the United States.
Founded
1992
HQ

Employees
280
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialCOSMAX Financials
COSMAX reported last 12-month revenue of $2B and EBITDA of $194M.
In the same LTM period, COSMAX generated $296M in gross profit, $194M in EBITDA, and $88M in net income.
Revenue (LTM)
COSMAX P&L
In the most recent fiscal year, COSMAX reported revenue of $2B and EBITDA of $184M.
COSMAX is profitable as of last fiscal year, with gross margin of 17%, EBITDA margin of 11%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
COSMAX Stock Performance
COSMAX has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
COSMAX's stock price is $112.49.
COSMAX share price decreased by 2.5% in the last 30 days, and by 40.2% in the last year.
COSMAX has an EPS (earnings per share) of $7.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | -1.5% | -2.5% | -15.6% | -40.2% | $7.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCOSMAX Valuation Multiples
COSMAX trades at 1.0x EV/Revenue multiple, and 8.6x EV/EBITDA.
EV / Revenue (LTM)
COSMAX Financial Valuation Multiples
As of June 3, 2026, COSMAX has market cap of $1B and EV of $2B.
COSMAX has a P/E ratio of 14.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified COSMAX Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


COSMAX Margins & Growth Rates
COSMAX grew revenue by 12% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, COSMAX reported gross margin of 17%, EBITDA margin of 11%, and net margin of 5%.
COSMAX Margins
COSMAX Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
COSMAX Operational KPIs
COSMAX's revenue per employee in the last FY averaged $5.8M, while opex per employee averaged $0.5M for the same period.
COSMAX's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
COSMAX's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
COSMAX Competitors
COSMAX competitors include Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings, Honasa Consumer, Sarantis Group, Perrigo, Procter & Gamble Health, Jamieson Wellness and SILICON2.
Most COSMAX public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.2x | 1.1x | 7.8x | 7.6x | |||
| 1.0x | 1.0x | 8.2x | 7.7x | |||
| 0.1x | - | 0.3x | - | |||
| 3.3x | 3.3x | 14.9x | 14.9x | |||
| 5.4x | 5.2x | 40.8x | 52.0x | |||
| 1.6x | 1.6x | 10.8x | 10.6x | |||
| 1.1x | 1.1x | 6.5x | 6.9x | |||
| 7.0x | - | 20.7x | - | |||
This data is available for Pro users. Sign up to see all COSMAX competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by COSMAX
COSMAX has acquired 2 companies to date.
Last acquisition by COSMAX was on February 22nd 2026. COSMAX acquired Keminova for undisclosed valuation.
Latest Acquisitions by COSMAX
| Description | Keminova is an Italian firm that manufactures and distributes skincare products alongside medical devices, focusing on wellness and therapeutic applications. | ART Lab is a direct-to-consumer cosmetics brand leveraging AI for personalized skincare formulations. Operating from its online platform, it analyzes user skin data to create custom products shipped directly to customers. The company focuses on tailored serums, creams, and treatments based on individual profiles derived from quizzes and image uploads processed by machine learning algorithms. |
| HQ Country | ||
| HQ City | - | Seoul |
| Deal Date | 22 Feb 2026 | 29 Nov 2024 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all COSMAX acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by COSMAX
COSMAX has invested in 1 company to date.
Latest investment by COSMAX was on October 12th 2020. COSMAX invested in Melixir in their $1M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by COSMAX
| Description | Melixir is a Seoul-based skincare brand producing plant-based products inspired by Korean hanbang herbal traditions. Its lineup includes mugwort calming creams, ginseng serums, and rice bran cleansers formulated for sensitive skin types. Certified B Corp, the company uses 100 percent vegan ingredients, cruelty-free testing, and sustainable packaging to minimize emissions, distributing through Sephora Korea and its online store. |
| HQ Country | |
| HQ City | San Francisco, CA |
| Deal Date | 12 Oct 2020 |
| Round | Seed |
| Raised | $1M |
| Investors | COSMAX; Dunamu & Partners |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all COSMAX investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout COSMAX
| When was COSMAX founded? | COSMAX was founded in 1992. |
| Where is COSMAX headquartered? | COSMAX is headquartered in South Korea. |
| How many employees does COSMAX have? | As of today, COSMAX has over 280 employees. |
| Is COSMAX publicly listed? | Yes, COSMAX is a public company listed on Korea Exchange. |
| What is the stock symbol of COSMAX? | COSMAX trades under 192820 ticker. |
| When did COSMAX go public? | COSMAX went public in 2014. |
| Who are competitors of COSMAX? | COSMAX main competitors include Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings, Honasa Consumer, Sarantis Group, Perrigo, Procter & Gamble Health, Jamieson Wellness, SILICON2. |
| What is the current market cap of COSMAX? | COSMAX's current market cap is $1B. |
| What is the current revenue of COSMAX? | COSMAX's last 12 months revenue is $2B. |
| What is the current revenue growth of COSMAX? | COSMAX revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of COSMAX? | Current revenue multiple of COSMAX is 1.0x. |
| What is the current EBITDA of COSMAX? | COSMAX's last 12 months EBITDA is $194M. |
| What is COSMAX's EBITDA margin? | COSMAX's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of COSMAX? | Current EBITDA multiple of COSMAX is 8.6x. |
| What is the current FCF of COSMAX? | COSMAX's last 12 months FCF is $3M. |
| What is COSMAX's FCF margin? | COSMAX's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of COSMAX? | Current FCF multiple of COSMAX is 569.0x. |
| How many companies COSMAX has acquired to date? | As of June 2026, COSMAX has acquired 2 companies. |
| What was the largest acquisition by COSMAX? | None of the M&A deals COSMAX has completed have disclosed valuations. |
| What companies COSMAX acquired? | COSMAX acquired Keminova and ART Lab. |
| In how many companies COSMAX has invested to date? | As of June 2026, COSMAX has invested in 1 company. |
| What was the last COSMAX investment? | On 12th October 2020 COSMAX invested in Melixir, participating in a $1M Seed round, alongside Dunamu & Partners. |
| In what companies COSMAX invested in? | COSMAX invested in Melixir. |
See public comps similar to COSMAX
Lists including COSMAX
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


